New shot could help lower stubborn high cholesterol
NCT ID NCT07278830
First seen Jan 08, 2026 · Last updated May 14, 2026 · Updated 16 times
Summary
This study tested a new injectable medicine called SAL003, given together with the common cholesterol pill atorvastatin, in 214 adults with high cholesterol or mixed dyslipidemia. The goal was to see if the combination could safely lower bad LDL cholesterol more than atorvastatin alone. Participants received either SAL003 or a placebo shot every few weeks for 24 weeks.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERCHOLESTEROLEMIA AND MIXED DYSLIPIDEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Sun Yat-sen Memorial Hospital, Sun Yat-sen University，Guangzhou，Guangdong，510120
Guangzhou, Guangdong, 510120, China
Conditions
Explore the condition pages connected to this study.